Yvette N Lowensteyn
Overview
Explore the profile of Yvette N Lowensteyn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access
Terstappen J, Hak S, Bhan A, Bogaert D, Bont L, Buchholz U, et al.
Lancet Infect Dis
. 2024 Sep;
24(12):e747-e761.
PMID: 39326422
Respiratory syncytial virus (RSV) is the second most common pathogen causing infant mortality. Additionally, RSV is a major cause of morbidity and mortality in older adults (age ≥60 years) similar...
2.
Mazur N, Lowensteyn Y, Terstappen J, Leusen J, Schobben F, Cianci D, et al.
EClinicalMedicine
. 2024 Jan;
66:102324.
PMID: 38192587
Background: Mucosal administration of monoclonal antibodies (mAbs) against respiratory pathogens is a promising alternative for systemic administration because lower doses are required for protection. Clinical development of mucosal mAbs is...
3.
Lowensteyn Y, Zheng Z, Rave N, Bannier M, Billard M, Casalegno J, et al.
J Infect Dis
. 2023 Jul;
228(10):1394-1399.
PMID: 37477906
We initiated a nationwide prospective study to monitor respiratory syncytial virus (RSV)-related pediatric hospitalizations in 46 hospitals throughout the Netherlands between May 2021 and August 2022. We showed year-round RSV...
4.
Lowensteyn Y, Willemsen J, Mazur N, Scheltema N, van Haastregt N, Ten Buuren A, et al.
Pediatr Infect Dis J
. 2022 Dec;
42(1):1-7.
PMID: 36476518
Background: According to the World Health Organization, the global burden of nosocomial infections is poorly characterized as surveillance systems are lacking. Nosocomial infections occur at higher rates in low- and...
5.
Lowensteyn Y, Mazur N, Nair H, Willemsen J, van Thiel G, Bont L
BMC Infect Dis
. 2021 Sep;
21(1):962.
PMID: 34530766
No abstract available.
6.
Mazur N, Lowensteyn Y, Willemsen J, Gill C, Forman L, Mwananyanda L, et al.
Clin Infect Dis
. 2021 Sep;
73(Suppl_3):S229-S237.
PMID: 34472576
Background: Respiratory syncytial virus (RSV) is a leading cause of pediatric death, with >99% of mortality occurring in low- and lower middle-income countries. At least half of RSV-related deaths are...
7.
Lowensteyn Y, Mazur N, Nair H, Willemsen J, van Thiel G, Bont L
BMC Infect Dis
. 2021 Aug;
21(1):857.
PMID: 34425773
Background: Respiratory syncytial virus (RSV) infection is an important cause of hospitalization and death in young children. The majority of deaths (99%) occur in low- and lower-middle-income countries (LMICs). Vaccines...
8.
Lowensteyn Y, Nair H, Nunes M, van Roessel I, Vernooij F, Willemsen J, et al.
EClinicalMedicine
. 2021 Aug;
37:100945.
PMID: 34386739
Background: Influenza virus infection is an important cause of under-five mortality. Maternal vaccination protects children younger than 3 months of age from influenza infection. However, it is unknown to what...
9.
Lowensteyn Y, Phijffer E, Simons J, Scheltema N, Mazur N, Nair H, et al.
Pediatr Infect Dis J
. 2020 Apr;
39(8):665-670.
PMID: 32332221
Background: Respiratory syncytial virus (RSV) is a major cause of mortality in children younger than 5 years worldwide. Systematic reviews have shown that Down syndrome (DS) is an independent risk...
10.
Lowensteyn Y, Bont L
Clin Infect Dis
. 2020 Jan;
71(11):2796-2798.
PMID: 31915814
No abstract available.